scispace - formally typeset
R

Robert J. Cerfolio

Researcher at University of Alabama at Birmingham

Publications -  234
Citations -  17425

Robert J. Cerfolio is an academic researcher from University of Alabama at Birmingham. The author has contributed to research in topics: Lung cancer & Thoracotomy. The author has an hindex of 60, co-authored 212 publications receiving 14461 citations. Previous affiliations of Robert J. Cerfolio include United States Department of Veterans Affairs & University of Alabama.

Papers
More filters
Journal ArticleDOI

Comprehensive molecular profiling of lung adenocarcinoma: The cancer genome atlas research network

Eric A. Collisson, +318 more
- 01 Jan 2014 - 
TL;DR: In this paper, the authors report molecular profiling of 230 resected lung adnocarcinomas using messenger RNA, microRNA and DNA sequencing integrated with copy number, methylation and proteomic analyses.
Journal ArticleDOI

Pan-cancer analysis of whole genomes

Peter J. Campbell, +1332 more
- 06 Feb 2020 - 
TL;DR: The flagship paper of the ICGC/TCGA Pan-Cancer Analysis of Whole Genomes Consortium describes the generation of the integrative analyses of 2,658 whole-cancer genomes and their matching normal tissues across 38 tumour types, the structures for international data sharing and standardized analyses, and the main scientific findings from across the consortium studies.
Journal ArticleDOI

The accuracy of integrated PET-CT compared with dedicated pet alone for the staging of patients with nonsmall cell lung cancer

TL;DR: Integrated PET-CT using FDG-18 better predicts stage I and II disease as well as the T and N status of patients with NSCLC when compared with dedicated PET alone.
Journal ArticleDOI

The maximum standardized uptake values on positron emission tomography of a non-small cell lung cancer predict stage, recurrence, and survival.

TL;DR: The maximum standard uptake value of a non-small cell lung cancer nodule on dedicated positron emission tomography is an independent predictor of stage and tumor characteristics and is a more powerful independent predictor than the TNM stage for recurrence and survival for patients with early-stage resected cancer.
Journal ArticleDOI

The Society of Thoracic Surgeons expert consensus for the surgical treatment of hyperhidrosis.

TL;DR: These studies suggest that primary hyperhidrosis of the extremities, axillae or face is best treated by endoscopic thoracic sympathectomy (ETS), and an international nomenclature should be adopted that refers to the rib levels instead of the vertebral level at which the nerve is interrupted, and how the chain is interrupted.